Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis
- PMID: 38837315
- DOI: 10.1002/ptr.8258
Curcumin suppresses colorectal cancer by induction of ferroptosis via regulation of p53 and solute carrier family 7 member 11/glutathione/glutathione peroxidase 4 signaling axis
Abstract
Driven by iron-dependent lipid peroxidation, ferroptosis is regulated by p53 and solute carrier family 7 member 11 (SLC7A11)/glutathione/glutathione peroxidase 4 (GPX4) axis in colorectal cancer (CRC). This study aimed to investigate the influence of curcumin (CUR) on ferroptosis in CRC. The efficacies of CUR on the malignant phenotype of CRC cells were determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide, wound healing, and clonogenic assays. The effects of CUR on ferroptosis of CRC cells were evaluated by transmission electron microscopy, lactate dehydrogenase release assay, Fe2+ staining, and analyses of reactive oxygen species, lipid peroxide, malondialdehyde, and glutathione levels. CUR's targets in ferroptosis were predicted by network pharmacological study and molecular docking. With SW620 xenograft tumors, the efficacy of CUR on CRC was investigated, and the effects of CUR on ferroptosis were assessed by detection of Fe2+, malondialdehyde, and glutathione levels. The effects of CUR on expressions of p53, SLC7A11, and GPX4 in CRC cells and tumors were analyzed by quantitative reverse transcription-polymerase chain reaction, western blotting, and immunohistochemistry. CUR suppressed the proliferation, migration, and clonogenesis of CRC cells and xenograft tumor growth by causing ferroptosis, with enhanced lactate dehydrogenase release and Fe2+, reactive oxygen species, lipid peroxide, and malondialdehyde levels, but attenuated glutathione level in CRC. In silico study indicated that CUR may bind p53, SLC7A11, and GPX4, consolidated by that CUR heightened p53 but attenuated SLC7A11 and GPX4 mRNA and protein levels in CRC. CUR may exert an inhibitory effect on CRC by inducing ferroptosis via regulation of p53 and SLC7A11/glutathione/GPX4 axis.
Keywords: GPX4; SLC7A11; colorectal cancer; curcumin; ferroptosis; p53.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Ponicidin triggered ferroptosis in esophageal squamous cell carcinoma by suppressing the SLC7A11/Glutathione/GPX4 signalling axis.Phytomedicine. 2025 Jul 25;143:156925. doi: 10.1016/j.phymed.2025.156925. Epub 2025 May 28. Phytomedicine. 2025. PMID: 40456202
-
Regulation of the p53/SLC7A11/GPX4 Pathway by Gentamicin Induces Ferroptosis in HEI-OC1 Cells.Otol Neurotol. 2024 Sep 1;45(8):947-953. doi: 10.1097/MAO.0000000000004271. Epub 2024 Aug 6. Otol Neurotol. 2024. PMID: 39072683 Free PMC article.
-
Dracorhodin perochlorate sensitizes colorectal cancer to ferroptosis by activating HMOX1 and inhibiting the SLC7A11/GPX4 axis.Int Immunopharmacol. 2025 Jun 17;158:114827. doi: 10.1016/j.intimp.2025.114827. Epub 2025 May 12. Int Immunopharmacol. 2025. PMID: 40359890
-
The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke.Brain Res Bull. 2024 Oct 15;217:111065. doi: 10.1016/j.brainresbull.2024.111065. Epub 2024 Sep 6. Brain Res Bull. 2024. PMID: 39243947 Review.
-
Recent Progress of Glutathione Peroxidase 4 Inhibitors in Cancer Therapy.Mini Rev Med Chem. 2025;25(1):42-57. doi: 10.2174/0113895575308546240607073310. Mini Rev Med Chem. 2025. PMID: 38879766 Review.
Cited by
-
Folic Acid Ameliorates Neuronal Ferroptosis in Aging by Up-Regulating SLC7A11-GSH-GPX4 Antioxidant Pathway and Increasing Cystine Levels.Int J Mol Sci. 2025 Jul 11;26(14):6669. doi: 10.3390/ijms26146669. Int J Mol Sci. 2025. PMID: 40724917 Free PMC article.
-
Therapeutic efficacy of ferroptosis in the treatment of colorectal cancer (Review).Oncol Lett. 2024 Sep 26;28(6):563. doi: 10.3892/ol.2024.14697. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39390976 Free PMC article. Review.
-
Natural products target programmed cell death signaling mechanisms to treat colorectal cancer.Front Pharmacol. 2025 Apr 24;16:1565332. doi: 10.3389/fphar.2025.1565332. eCollection 2025. Front Pharmacol. 2025. PMID: 40342991 Free PMC article. Review.
-
Natural anti-cancer products: insights from herbal medicine.Chin Med. 2025 Jun 9;20(1):82. doi: 10.1186/s13020-025-01124-y. Chin Med. 2025. PMID: 40490812 Free PMC article. Review.
-
Computational investigation of naturally occurring anticancer agents in regulating Hedgehog pathway proteins.PLoS One. 2024 Dec 3;19(12):e0311307. doi: 10.1371/journal.pone.0311307. eCollection 2024. PLoS One. 2024. PMID: 39625914 Free PMC article.
References
REFERENCES
-
- Battaglia, A. M., Chirillo, R., Aversa, I., Sacco, A., Costanzo, F., & Biamonte, F. (2020). Ferroptosis and cancer: Mitochondria meet the “iron maiden” cell death. Cells, 9(6), 1505. https://doi.org/10.3390/cells9061505
-
- Bhatt, H. D., McClain, S. A., Lee, H. M., Zimmerman, T., Deng, J., Johnson, F., Gu, Y., & Golub, L. M. (2022). The maximum‐tolerated dose and pharmacokinetics of a novel chemically modified curcumin in rats. Journal of Experimental Pharmacology, 14, 73–85. https://doi.org/10.2147/JEP.S341927
-
- Cao, X., Li, Y., Wang, Y., Yu, T., Zhu, C., Zhang, X., & Guan, J. (2022). Curcumin suppresses tumorigenesis by ferroptosis in breast cancer. PLoS One, 17(1), e0261370. https://doi.org/10.1371/journal.pone.0261370
-
- Chen, H., Li, Z., Xu, J., Zhang, N., Chen, J., Wang, G., & Zhao, Y. (2023). Curcumin induces ferroptosis in follicular thyroid cancer by upregulating HO‐1 expression. Oxidative Medicine and Cellular Longevity, 2023, 6896790. https://doi.org/10.1155/2023/6896790
-
- Chen, H., Wang, C., Liu, Z., He, X., Tang, W., He, L., Feng, Y., Liu, D., Yin, Y., & Li, T. (2022). Ferroptosis and its multifaceted role in cancer: Mechanisms and therapeutic approach. Antioxidants (Basel), 11(8), 1504. https://doi.org/10.3390/antiox11081504
MeSH terms
Substances
Grants and funding
- 81573813/National Natural Science Foundation of China
- 2023NSFSC0653/The Science & Technology Department of Sichuan Province of China
- 2021XYCZ007/Sichuan Provincial Administration of Traditional Chinese Medicine of China
- 2021MS447/Sichuan Provincial Administration of Traditional Chinese Medicine of China
- 21PJ107/Health Commission of Sichuan Province of China
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous